drugset / Trial / NCT05812924
A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause
NaSingle-groupOpen-labelSupportive care
Summary
The purpose of this study is to determine whether platelet rich plasma (PRP) injections to the vulva and vagina will improve symptoms of genitourinary syndrome of menopause (GSM) in breast cancer patients.
Timeline
- Start
- 2023-09-26
- Primary completion
- 2026-09-30
- Completion
- 2026-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Platelet Rich Plasma | Other / unclassified | — | Other |